Carrese, B.; Cavallini, C.; Sanità , G.; Armanetti, P.; Silvestri, B.; Calì, G.; Pota, G.; Luciani, G.; Menichetti, L.; Lamberti, A.
Controlled Release of Doxorubicin for Targeted Chemo-Photothermal Therapy in Breast Cancer HS578T Cells Using Albumin Modified Hybrid Nanocarriers. Int. J. Mol. Sci. 2021, 22, 11228.
https://doi.org/10.3390/ijms222011228
AMA Style
Carrese B, Cavallini C, Sanità G, Armanetti P, Silvestri B, Calì G, Pota G, Luciani G, Menichetti L, Lamberti A.
Controlled Release of Doxorubicin for Targeted Chemo-Photothermal Therapy in Breast Cancer HS578T Cells Using Albumin Modified Hybrid Nanocarriers. International Journal of Molecular Sciences. 2021; 22(20):11228.
https://doi.org/10.3390/ijms222011228
Chicago/Turabian Style
Carrese, Barbara, Chiara Cavallini, Gennaro Sanità , Paolo Armanetti, Brigida Silvestri, Gaetano Calì, Giulio Pota, Giuseppina Luciani, Luca Menichetti, and Annalisa Lamberti.
2021. "Controlled Release of Doxorubicin for Targeted Chemo-Photothermal Therapy in Breast Cancer HS578T Cells Using Albumin Modified Hybrid Nanocarriers" International Journal of Molecular Sciences 22, no. 20: 11228.
https://doi.org/10.3390/ijms222011228
APA Style
Carrese, B., Cavallini, C., Sanità , G., Armanetti, P., Silvestri, B., Calì, G., Pota, G., Luciani, G., Menichetti, L., & Lamberti, A.
(2021). Controlled Release of Doxorubicin for Targeted Chemo-Photothermal Therapy in Breast Cancer HS578T Cells Using Albumin Modified Hybrid Nanocarriers. International Journal of Molecular Sciences, 22(20), 11228.
https://doi.org/10.3390/ijms222011228